# FY26 Pediatric FLU Canonical: https://abierto.us/opportunities/75d30125r73357 - Solicitation number: 75D30125R73357 - Notice type: Combined synopsis and solicitation - Status: Awarded to Astrazeneca Pharmaceuticals LP - Department: Department of Health and Human Services - Agency: Centers for Disease Control and Prevention - Contracting office: CDC Office of Acquisition Services (75D301) - NAICS: 325412 Pharmaceutical Preparation Manufacturing - Product or service code: 6505 Drugs and Biologicals - Place of performance: Atlanta, Georgia - City: Atlanta. https://abierto.us/cities/atlanta-ga-1304000 - First posted: August 14, 2025 - Last posted: August 19, 2025 - SAM.gov: https://sam.gov/workspace/contract/opp/6373eef4cfad4de0acaed645596b2b50/view ## Description The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine ## Award on USAspending - Recipient: Astrazeneca Pharmaceuticals LP (UEI E5K2ZJ8CTJH4) - Contract: 75D30126D20713 - Obligated: $122,760.00 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20713_7523/ - Recipient: Glaxosmithkline, LLC (UEI FRHTPHMZMX47) - Contract: 75D30126D20714 - Obligated: $4,999,740.48 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20714_7523/ - Recipient: Sanofi Vaccines US Inc. (UEI NCXBGGQ8YTU9) - Contract: 75D30126D20717 - Obligated: $2,000,377.66 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20717_7523/ - Recipient: Seqirus USA Inc. (UEI N6U7P2B9VHS5) - Contract: 75D30126D20720 - Obligated: $1,004,522.04 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20720_7523/ - Recipient: Astrazeneca Pharmaceuticals LP (UEI E5K2ZJ8CTJH4) - Contract: 75D30126D20723 - Obligated: $9,746,831.60 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20723_7523/ - Recipient: Glaxosmithkline, LLC (UEI FRHTPHMZMX47) - Contract: 75D30126D20724 - Obligated: $81,300,000.96 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20724_7523/ - Recipient: Sanofi Vaccines US Inc. (UEI NCXBGGQ8YTU9) - Contract: 75D30126D20725 - Obligated: $68,661,449.49 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20725_7523/ - Recipient: Seqirus USA Inc. (UEI N6U7P2B9VHS5) - Contract: 75D30126D20726 - Obligated: $57,772,604.95 - Competition: Full and Open Competition, 4 offers received - Link: solicitation number 75D30125R73357 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence) - Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20726_7523/ ## Publications - August 14, 2025: Combined synopsis and solicitation, due August 28, 2025 at 1:00 PM EDT. Notice e62f4dc5ffda4a6995908b7c831faa69. https://sam.gov/workspace/contract/opp/e62f4dc5ffda4a6995908b7c831faa69/view - August 19, 2025: Combined synopsis and solicitation, due August 28, 2025 at 1:00 PM EDT. Notice 2d957bd88a9840a7961edda96d317295. https://sam.gov/workspace/contract/opp/2d957bd88a9840a7961edda96d317295/view - August 19, 2025: Combined synopsis and solicitation, due August 28, 2025 at 1:00 PM EDT. Notice 6373eef4cfad4de0acaed645596b2b50. https://sam.gov/workspace/contract/opp/6373eef4cfad4de0acaed645596b2b50/view ## Points of contact - James Sprigler, zbs6@cdc.gov - Chad Turner, ukr9@cdc.gov --- Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75d30125r73357.